Concord Biotech Ltd.(IN:CONCORDBIO)
₹579.50-15.00 (-2.52%)
IN:CONCORDBIO
Concord Biotech Ltd. financials statements
₹579.50
At close:-15.00 (-2.52%)
Want to see IN:CONCORDBIO full AI Analyst Report?
Concord Biotech Ltd. (CONCORDBIO) Income Statement
4 Followers
Concord Biotech Ltd. Income Statement
Last quarter (Q2 2027), Concord Biotech Ltd.'s total revenue was ₹3.09B, an increase of 25.10% from the same quarter last year. In Q2, Concord Biotech Ltd.'s net income was ₹706.53M. See Concord Biotech Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| ₹ 10.55B | ₹ 12.00B | ₹ 10.17B | ₹ 8.53B | ₹ 7.13B | |
| ₹ 4.42B | ₹ 7.68B | ₹ 6.67B | ₹ 6.61B | ₹ 5.41B | |
| ₹ 1.49B | ₹ 1.66B | ₹ 1.46B | ₹ 1.43B | ₹ 1.25B | |
| Depreciation and Amortization | ₹ 744.59M | ₹ 543.74M | ₹ 535.91M | ₹ 540.32M | ₹ 500.50M |
| ₹ 4.19B | ₹ 5.14B | ₹ 4.40B | ₹ 3.54B | ₹ 2.79B | |
| ₹ 2.93B | ₹ 6.02B | ₹ 5.21B | ₹ 5.18B | ₹ 4.16B | |
| ₹ 517.06M | ₹ -1.07B | ₹ -1.09B | ₹ -1.96B | ₹ -1.79B | |
| ₹ 3.45B | ₹ 4.95B | ₹ 4.13B | ₹ 3.22B | ₹ 2.38B | |
| ₹ 2.61B | ₹ 3.72B | ₹ 3.08B | ₹ 2.40B | ₹ 1.75B | |
| Per Share Metrics | |||||
| Basic EPS | ₹ 12.39 | ₹ 17.76 | ₹ 14.72 | ₹ 11.47 | ₹ 8.36 |
| Diluted EPS | ₹ 12.39 | ₹ 17.76 | ₹ 14.72 | ₹ 11.47 | ₹ 8.36 |
| Weighted Average Shares Outstanding | 210.58M | 209.23M | 209.23M | 209.23M | 209.23M |
| Weighted Average Shares Outstanding (Diluted) | 210.58M | 209.23M | 209.23M | 209.23M | 209.23M |
Currency in INR

